tirzepatide penis 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often Semaglutide vs. Tirzepatide vs. Retatrutide:

Patented ingredient extracted from New Zealand feijoa (International Patent WO 2013/186680 A1)

Type 2 diabetes (formulation R2) Starting (Day 1 to 30): 1.5 mg once daily for 30 days (this dosage is not effective for glycemic control) Escalation and Maintenance Dosage: Days 31 to 60: Increase the dosage to 4 mg orally once daily Day 61 and on: If blood sugars are controlled, continue 4 mg once daily

Again, it isn't necessarily bad just still a bit odd

The dose levels of semaglutide both in IcoSema (0.114 mg) and when dosed alone (0.1072 mg) were lower in the current study compared with the previous study (0.5 mg) [16] and most likely explains the overall lower frequency of gastrointestinal related AEs in the current study

After the end of the experiment, blood samples were taken for biochemical tests